methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate

C24H26N4O8 — CID 10163850

IUPACmethyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate
SMILESCOC(=O)C(CO)NC(=O)c1ccc(N2CCC(N3C(=O)OCc4ccccc43)CC2)c([N+](=O)[O-])c1
InChIInChI=1S/C24H26N4O8/c1-35-23(31)18(13-29)25-22(30)15-6-7-20(21(12-15)28(33)34)26-10-8-17(9-11-26)27-19-5-3-2-4-16(19)14-36-24(27)32/h2-7,12,17-18,29H,8-11,13-14H2,1H3,(H,25,30)
InChIKeyQMFRHKAFSXCELM-UHFFFAOYSA-N
MW498.49 g/mol
LogP1.98
Rot. Bonds7

About methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate

methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate (PubChem CID 10163850) has the molecular formula C24H26N4O8 and a molecular weight of 498.49 g/mol. Its IUPAC name is methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate.

Molecular Properties

Compound Namemethyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate
PubChem CID10163850
Molecular FormulaC24H26N4O8
Molecular Weight498.49 g/mol
Exact Mass498.18
IUPAC Namemethyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate
SMILESCOC(=O)C(CO)NC(=O)c1ccc(N2CCC(N3C(=O)OCc4ccccc43)CC2)c([N+](=O)[O-])c1
InChIInChI=1S/C24H26N4O8/c1-35-23(31)18(13-29)25-22(30)15-6-7-20(21(12-15)28(33)34)26-10-8-17(9-11-26)27-19-5-3-2-4-16(19)14-36-24(27)32/h2-7,12,17-18,29H,8-11,13-14H2,1H3,(H,25,30)
InChIKeyQMFRHKAFSXCELM-UHFFFAOYSA-N
XLogP1.98
TPSA151.55 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500498.49
LogP ≤ 51.98
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate?
The IUPAC name of methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate (CID 10163850) is methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate.
What is the SMILES notation for methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate?
The canonical SMILES for methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate is COC(=O)C(CO)NC(=O)c1ccc(N2CCC(N3C(=O)OCc4ccccc43)CC2)c([N+](=O)[O-])c1.
What is the InChIKey of methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate?
The InChIKey is QMFRHKAFSXCELM-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26N4O8/c1-35-23(31)18(13-29)25-22(30)15-6-7-20(21(12-15)28(33)34)26-10-8-17(9-11-26)27-19-5-3-2-4-16(19)14-36-24(27)32/h2-7,12,17-18,29H,8-11,13-14H2,1H3,(H,25,30).
What are the key properties of methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate?
methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate has a molecular weight of 498.49 g/mol, XLogP of 1.98, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 3-hydroxy-2-[[3-nitro-4-[4-(2-oxo-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]benzoyl]amino]propanoate is sourced from PubChem (CID 10163850), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).